A B S T R A C T Administration of phenobarbital, which acts exclusively on cellular sites, results in an augmentation of the liver/plasma concentration ratio of L-thyroxine (T4) in rats but no change in the liver/plasma concentration ratio of L-triiodothyronine (T3). Whereas phenobarbital stimulates the fecal clearance rate both of T3 and T4, it increases the deiodinative clearance rate of T4 only. These findings suggest basic differences in the cellular metabolism of T3 and T4. Further evidence pointing to cellular differences was obtained from a comparison of the distribution and metabolism of these hormones with appropriate corrections for the effect of differential plasma binding. The percentage of total exchangeable cellular T4 within the liver (28.5) is significantly greater than the corresponding percentage of exchangeable cellular T3 within this organ (12.3). Extrahepatic tissues bind T3 twice as firmly as T4. The cellular metabolic clearance rate (= free hormone clearance rate) of T3 exceeds that of T4 by a factor 1.8 in the rat. The corresponding ratio in man, 2.4, was determined by noncompartmental analysis of turnover studies in four individuals after the simultaneous injection of T4-'I and T3-2"I. The greater cellular metabolic clearance rate of T3 both in rat and man may be related to the higher specific hormonal potency of this iodothyronine.
INTRODUCTION
It is widely recognized that 3,5,3'-L-triiodothyronine (T3) has a larger space of distribution and a more rapid fractional turnover rate than L-thyroxine (T4) both in man (1, 2) and the rat (3) . Although these differences can be attributed, at least in part, to the fact that T4 is more firmly bound to plasma proteins than T3, no specific studies have been undertaken to determine to what extent intrinsic cellular factors may be involved. We became interested in this general question in connection with our studies of the effect of phenobarbital administration on thyroid hormone metabolism. Differences in the tissue response of T3 and T4 pointed to distinctive patterns of cellular handling of these hormones and prompted us to undertake a comparison of the cellular and plasma protein factors determining the distribution and metabolism of the thyroid hormones. The current report describes the results of these studies. Our findings indicate significant differences in the primary cellular determinants of T3 and T4 metabolism, factors which may be related to differences in the metabolic potency of these hormones.
METHODS
Male Sprague-Dawley rats (150-250 g) were supplied by Carworth Farms (New City, N. Y.) and maintained on a Purina Laboratory Chow diet.
Radioactive iodothyronines labeled in the phenolic ring with 'I and 13"I (specific activity [SA] range for both T3 and T4: 30-50 mCi/mg) and 'I-labeled human serum albumin (SA approximately 1 ,Ci/mg) were obtained from Abbott Laboratories, North Chicago, Ill. Radioactive T4 was purified by dialysis for 24 hr according to the method described by Schussler and Plager (4) . This technique serves to remove ligands less tightly bound to plasma proteins than T4. Preparations of radioactive T3 were dialyzed for only 2 hr in order to remove contaminating radioactive iodide. After dialysis, preparations contained less than 5% contaminating radioactive material by paper chromatography in conventional solvent systems. All radioactive samples were counted to a statistical accuracy ±2% in a two-channel Autogamma Spectrometer (Packard). In order to insure geometric uniformity, whole tissue samples were digested in 2 N NaOH before counting. When both "~'I and 'fI were measured simultaneously, appropriate corrections were made for the "spill-over" of "S'I into 36 kev range at which 'I was measured. All samples were compared with simultaneously counted aliquots of the original dose so as to obviate the necessity of additional corrections for physical decay. Radioactive doses were diluted in 1%o human albumin and injected intravenously through the tail vein under light ether anesthesia. Blood samples were obtained from the cut tail and from the abdominal aorta at the end of the study.
In our kinetic analysis we assumed that all radioactivity in plasma and tissues was in the form of iodide or the injected substance. This assumption was based on paper chromatographic analyses (hexane: tertitary amyl alcohol: 2 N ammonia) (5) of tissue and plasma extracts obtained 17 hr after the injection of 30 ACi T4-'uI and 30 uCi T3-'5I. 2 g equivalent of liver, kidney, and homogenate and 1 ml plasma were extracted with four volumes of 95%, ethanol X 4. The pooled extracts were evaporated to dryness in vacuo and the residue taken up in methanol-ammonia (3: 1). Over 90% of the radioactivity was in the form of the injected radioactivity and iodide. Since all experiments were conducted within 24 hr after injection of the tracers, the contribution of nonextractable iodine to the total tissue and plasma radioactivity was negligible (6, 7) .
Because of variable deiodination (10-20%) during the chromatography of tissue and plasma samples, the contribution of iodide was determined by alternative techniques.
In the case of plasma, concentration of radioactive iodide was assessed either by rapid paper electrophoresis or by trichloroacetic acid (TCA) precipitation. In the case of tissues, the iodide contribution was estimated either by TCA precipitation or from the product of the predetermined iodide space and the plasma iodide concentration. For liver and kidney, the iodide contribution could be effectively ignored since the estimated iodide concentration was consistently less than 10% of the total tissue radioactivity. The effect of phenobarbital. The effect of phenobarbital stimulation on the liver/plasma concentration ratio of T3 and T4 was determined after 5 days of pretreatment with phenobarbital (100 mg/kg intraperitoneally) (8) . Animals were sacrificed 35 min after intravenous injection of a combined dose of 2 ,uCi of T4-'1I and 1 ,uCi of T3-'3'I. It was assumed on the basis of previous experiments that each gram of liver contained the equivalent of 0.1 ml of trapped plasma. Correction for trapped plasma reduced the apparent T4 concentration in the liver by 20% but had no substantial effect (less than 5%) on the liver concentration of T3 because of the high liver/plasma ratio for T3. Subcellular distribution of the iodothyronines was determined according to the method of Schneider and Hogeboom (9) . It was assumed on the basis of our previous studies (10) that all trapped plasma proteins were included in the supernatant fraction.
The effect of phenobarbital on the metabolism of T3 was determined in a group of five control animals and five animals pretreated with phenobarbital for 5 days. The kinetic analysis was similar to that previously used to determine the metabolic clearance of T4 (11) . 2 ,uCi of T3-'uI was injected intravenously and serial plasma samples were obtained 3, 17, and 24 hr after injection of the dose. Animals also received an intraperitoneal injection of 1 mg NaI in order to prevent thyroidal accumulation of radioactive iodide.
Plasma T3 concentrations were calculated as the difference between the plasma total 'I concentration and the iodide-'rI concentration as determined by paper electrophoresis. A rectilinear plasma decay between 3 and 24 hr was observed on a semilogarithmic plot. The T3 distribution volume was obtained from the reciprocal of the zero time intercept and the metabolic clearance rate was calculated from the product of the total distribution volume and the fractional plasma disappearance rate. Urinary and fecal collections were also obtained during this period. Fecal pellets in the colon obtained after sacrificing the animals were pooled with excreted feces. The fecal clearance rate was estimated from the product of the metabolic clearance rate and the fraction of total excreted radioactivity in the feces. The deiodinative clearance rate was calculated from the product of the metabolic clearance rate and the fraction of total excreted radioactivity found in the urine. Electrophoresis of the urine indicated that over 95% of the radioactivity was in the form of iodide. The nature of the fecal radioactivity was not analyzed.
Comparison of cellular binding and metabolism of T3 and T4. The partition of T4 and T3 among various body compartments was assessed. Six animals were injected intravenously with a combined dose of 2 AGCi albumin-'I and 4,Ci T4-'I and six animals were injected with 4 ,tCi T3-5I only. Animals were placed in individual metabolic cages for separate collection of urine and feces. 17 hr after injection the animals were killed. Since the plasma disappearance curve of T4, T3, and albumin was in the exponential phase, distribution equilibrium could be assumed.' The livers and kidneys were separately removed and plasma samples were obtained. The stomach and the intestines were totally removed and the gut contents were expressed and pooled with the fecal collection. The gut and the remaining carcass were combined, passed through a manual meat grinder, and homogenized in a Waring Blendor. Weighed samples were solubilized with concentrated NaOH. Residual iodide in the carcass was estimated on the basis of the product of the plasma radioactive iodide concentration and an iodide space of 48.3 ml/100 g body weight estimated on the basis of plasma iodide disappearance kinetics in 10 separate animals.
In the animals injected with a combined dose of albumin-"31I and T4-'5I appropriate corrections for tissue or carcass T4 bound to trapped plasma proteins were made on the basis of the albumin-"3'I counting rates and the T4/albumin counting ratios in the plasma. In the animals injected with T3 alone corrections for T3 bound to trapped plasma proteins were made on the basis of the mean albumin distribution volume determined in the paired animals injected with the combined dose of albumin and T4. The assumption was made that the distribution volume of the T3-binding proteins is the same as that of serum albumin. The relative strength of binding of T4 and T3 to plasma proteins was assessed by simultaneous equilibrium dialysis of tracer quantities of T4-'3'I and T3-'1I added to the same serum samples (13) . The ratio of the net strength of plasma binding of T4, b4, to the net strength of plasma binding of T3, b3, was calculated from the expression b4 I -DF4 X DF3 b3 1-DF3 DF4 where DF3 and DF4 are the dialyzable fractions of T3 and T4 as previously defined (13) . This relationship is apparent from the following considerations. The net strength of plasma protein is defined as the sum of the products of the association constant (ki) of each of n classes of binding sites and the concentration of unoccupied binding sites Pi. Thus either for T3 or T4 n b = EkiPi From the law of mass action as pointed out by Robbins and Rall (14) . 
DF3
Studies in man. In order to ascertain possible differences in the intrinsic cellular handling of T3 and T4 in man, studies were performed in two euthyroid convalescing patients and two healthy normal volunteers. A combined dose of 40 /ACi T3-'I and 20 /ACi T4-1'I was injected intravenously.
Blood samples were obtained 10 min and 2, 5, 10 and 24 hr after injection. Thereafter, samples were obtained twice a day for 5 days and subsequently once daily until 2 wk after injection. All subjects received 5 drops of Lugol's solution three times a day during the study. Plasma samples were subjected to TCA precipitation to remove inorganic iodide and extracted four times with ethanol in order to measure nonextractable iodine as previously described (6) . The difference between the TCA-precipitable iodine and nonextractable iodine was considered to be iodothyronine. Data were analyzed by the noncompartmental approach proposed by Tait (15 
RESULTS
Comparison of the effect of phenobarbital administration on the distribution and turnover of T3 and T4 in the rat. A difference in the effect of phenobarbital administration on the partition of T4 and T3 between liver and plasma is demonstrated by the data summarized in Table I . Phenobarbital treatment resulted in an 82% increase in the liver/plasma (L/P) concentration ratio of T4-'I, in agreement with previous results (8), but no change in the L/P concentration ratio of simultaneously administered T3-V'3I. Previous experiments had indicated that phenobarbital does not affect the plasma binding of T4 (8) . Similarly in the current studies, equilibrium dialysis revealed no significant difference between the binding of T3 by plasma proteins in control and in phenobarbital-treated animals (control DF [n = 11]: 36.8 ±7.1 [SD] %; phenobarbital [n = 12]: 31.6 ±5.7 [sD] %). Thus, we concluded that the failure to demonstrate an increase in the L/P concentration ratio of T3 was due to failure of phenobarbital administration to induce an over-all increase in the binding of T3 by hepatocellular tissue.
Results of the subcellular fractionation studies summarized in Table I may provide at least a partial explanation of this difference. A much larger fraction of total cellular T3 is associated with the supernatant fraction (36.9%) than in the case of T4 (17.6%). Conversely, a larger proportion of cellular T4 is bound to microsomes (45.8%) than is T3 (33.0%). Previous studies have suggested that the increase in total hepatocellular binding of T4 is due largely to microsomal proliferation (10) . Since T3 is associated to a larger extent than T4 with nonmicrosomal sites, the increase in microsomal binding indicated in Table I might not be reflected as clearly in the L/P ratio of T3 as in the case of T4. Redistribution of T3 among subcellular fraction during homogenization, however, cannot be rigorously excluded.
Other differences in the response of T3 and T4 to the administration of phenobarbital were found in turnover experiments. In previous studies (7) we observed that phenobarbital administration resulted in a 30% increase in the turnover rate of T3V'I whereas a 61% increase had been noted with T4 (11) . In an additional study (Table II) , we again noted only a 38% increase in the metabolic clearance rate of T3--lI after phenobarbital treatment. The relative increase in fecal clear- (11) . The t2 of T3 in the total body experiments was 7.4 hr compared to 8.8 hr from the plasma disappearance curve (Table II) . The total distribution volume of T4 in these experiments was 16.4 ml/100 g body weight, compared to 15.6 ml/100 g from plasma measurements. The total distribution volume for T3, 165 ml/ 100 g, however, was less than the value of 265 ml/100 g in Table II . The total metabolic clearance rate per 100 g body weight for T4 was 0.83 ml/hr (plasma kinetics, 0.70 ml/hr) and for T3, 15.3 ml/hr (plasma kinetics, 20.9 ml/hr).
In these experiments, the total amount of tracer hormone deiodinated was determined from the sum of the residual body iodide and the urinary iodide excretion. The fecal excretion was estimated from the sum of radioactivity in the gut and in the feces. On the basis of these values the fecal and deiodinative clearance rates were calculated (Table III) . The fecal clearance rate of T4 constituted about 54% of the total metabolic clearance rate, in confirmation of previous studies (11) . Similarly, the fecal clearance rate of T3 was found to be 47% of the metabolic clearance rate.
As is apparent from the Appendix, the total metabolic clearance rate, fractional turnover rate, and distribution spaces are dependent on both primary cellular factors and on the strength of plasma protein binding of the thyroid hormones. In order to assess the cellular contributions to the observed differences in these parameters and in order to calculate the ratio of the cellular binding of T3 and T4 in individual tissues, the comparative strength of plasma protein binding of T4 and T3 was The cellular handling of iodothyronines can be expressed in terms of two variables, the fractional removal of hormone from the pooled cellular compartment (kc) and the binding of hormone by the pooled cellular compartment (Be). The product of these two terms can be defined as the cellular metabolic clearance rate (kGB ,) and can be shown to be numerically equivalent to the free hormone clearance rate (Appendix, equation 10). The cellular metabolic clearance rate is a measure of the total metabolic clearance rate corrected for effects of plasma binding. It is also possible to calculate the cellular binding of individual tissues. The ratios of these functions (T3/T4), derived as indicated in the Appendix (equations 3, 4, 7, and 9), are listed in Table IV. It is apparent that the net cellular binding and the cellular metabolic clearance rate of T3 exceed those of T4. Similarly, the cellular binding of T3 by kidney and carcass exceeds that of T4. In the case of the liver, however, the strength of binding of both hormones is approximately the same. In essence, these results show that the increased distribution volume of T3 and its greater metabolic clearance rate cannot be attributed exclusively to diminished plasma binding of T3. These results also indicate that the increased binding of T3 by extrahepatic tissues is primarily responsible for the smaller fraction of total cellular T3 within the liver as compared to T4.
Comparison of the cellular metabolism of T3 and T4 in man. The results of studies in the rat prompted us to determine whether differences also exist between the cellular metabolism of T3 and T4 in man. The opportunity to obtain multiple plasma samples in man facilitated adoption of a noncompartmental kinetic analysis. 
DISCUSSION
The results of these studies point to important differences in the cellular handling of T3 and T4. This conclusion is apparent from an analysis of the effects of phenobarbital on T3 and T4 metabolism, a comparison of the subcellular distribution of T3 and T4, and calculation of intrinsic cellular determinants of hormonal distribution and metabolism. In particular, our studies suggest that a smaller fraction of the total cellular T3 is situated within the liver than is the case with T4. The failure to demonstrate an increase in deiodinative clearance rate of T3 after phenobarbital administration also raises the possibility that the liver makes a substantially smaller contribution to the total deiodination of T3 in comparison to its role in the deiodination of T4. This concept is supported by recent studies from our labortory in which we have demonstrated that the ratio of the concentration of nonextractable iodine in liver to other tissues after injection of radioactive T3 is less than the corresponding ratio after the injection of T4-'I (7).
In these studies we have also supplied evidence that there is a direct correlation between deiodination and the formation of iodinated tissue proteins.
On the other hand, the finding that the proportion of total hormonal flux cleared via the fecal route is the same for T3 and T4 suggests that a larger fraction of hepatocellular T3 is excreted into the bile per unit time. This conclusion is based on two assumptions: (a) that fecal radioactivity results exclusively from the difference between biliary excretion and enteric reabsorption, and (b) that the fractional rate of enteric reabsorption of T3 is the same as that of T4. The increased metabolic clearance rate of T3 after phenobarbital administration would appear to result largely from an increase in fecal and, presumably, an enhanced biliary clearance rate. No increase in deiodinative clearance rate was detected in contrast to our previous observations with T4. The anatomic basis for the differential hepatocellular handling of T3 and T4 remains obscure. The finding that a large proportion of hepatocellular T3 is associated with the cytosol highlights the possible importance of soluble intracellular binding proteins such as those described by Hamada, Torizuka, and Miyake (16). The conclusion that the proportion of total cellular iodothyronine within the liver is larger for T4 than for T3 confirms the earlier findings of Van Arsdel, Hogness, Williams, and Elgee (3). Our results are also consonant with the findings of Heninger, Larson, and Albright who found that T3/T4 ratio in liver was lower than that in most other tissues after equilibration with dietary "I- (17) . These observations mitigate against the possibility that the differential isotopic distribution which we and Van Arsdel et al. observed do not reflect nonradioactive hormone distribution. Lastly, Cavalieri, Steinberg, and Searle, by use of constant infusion techniques, have estimated that the liver distribution space of T3 in normal males is 2.75 liters (18) . Assuming a total cellular distribution of space of T3 of 33 liters (= total T3 distribution space of 40 liters [5] -albumin space of 7 liters [19] ) the hepatic space of T3 would constitute only 8.3% of the total cellular T3 space. The same authors have estimated that the hepatic distribution space of T4 is 3.8 liters (20) . The cellular distribution volume of T4 estimated from the difference of the total distribution volume given by these authors, 12.4 liters, and the protein distribution space of 7 liters is 5.4 liters. Thus, hepatic T4 would appear to constitute 68% of the total cellular space. Although, these calculations are subject to considerable experimental error, the striking difference between T3 and T4 in hepatic contribution to total exchangeable iodothyronine strongly supports the findings of this report.
The difference in the partition of T3 between liver and extrahepatic tissue theoretically could be due either to increased binding by extrahepatic tissues or to decreased hepatocellular binding or to both. Our analysis would suggest that the primary factor responsible for the observed data in the rat is increased binding of T3 by extrahepatic tissues. This conclusion was derived from an analysis of the tissue/plasma concentration ratio after establishment of isotopic distribution and measurement of the relative strength of plasma protein binding of T3 and T4 by equilibrium dialysis. We determined that T4 was bound to plasma proteins about 10 times as avidily as T3 both in man and the rat. This finding agrees with previous estimates (21, 22 is a larger cellular clearance rate of T3, a finding which is related to the fractional removal rates from the cellular pools of T3 and T4 (kc) which can be calculated to be about 0.7 and 0.2 (day-') respectively. The difference in the cellular metabolic clearance rates in man is therefore determined by the fractional removal of the intracellular hormones whereas in the rat, the difference in cellular metabolic clearance rates is determined by cellular binding of T3 and T4. The calculated fractional removal rates of intracellular T3 and T4 in the rat are approximately the same.
The kinetic difference between rat and man may be a simple reflection of the percentage of total cellular binding sites which are metabolically linked. Since it is difficult experimentally to determine the proportion of cellular binding sites which are metabolically linked it is more convenient for most purposes simply to determine the cellular metabolic clearance rate, Bck., which is numerically equal to the free hormone clearance rate, a concept previously used by Ingbar, Braverman, Dawber, Lee (21) . Determination of total cellular binding, however, can be useful under certain circumstances in obtaining indications about the precise tissue or organ in which metabolic changes occur. Thus, demonstration of increased hepatocellular binding of T4 after phenobarbital administration was helpful in inferring that the increase in total turnover was due to the liver.
It is interesting to speculate about the relationship between the increased cellular metabolic clearance of T3 and its greater specific metabolic potency compared to T4 (24) . It has been suggested that the biological action of thyroid hormones is related to their metabolism (25) . The finding that the ratio of the cellular metabolic clearance rate of T3 to T4 is about the same in man and the rat despite differences in the cellular binding relationship supports this concept. If the increased specific hormonal potency is related to the increased cellular metabolic clearance rate, one would also have to infer that such differences are due to extrahepatic sites since our data would suggest that the liver probably deiodinates a smaller proportion of total body T3 than T4. The proportion of thyroid hormone which is cleared via the enteric tract probably is not related to the metabolic action of the hormone (26) . Although these considerations are speculative they are capable of critical testing in further experiments.
APPENDIX
Under equilibrium conditions the total body pool of an exchangeable strongly protein-bound hormone may be considered to be distributed between plasma protein and cellular compartments. For T3 and T4, the total amount of hormone in the "free" form can be neglected as a first approximation.
If we assume validity of single-compartment kinetics for the sake of simplicity, the following relationships can be derived. (1) Similarly, for an individual tissue or organ we can define cellular binding bi so that bi ci* bp cp* where ci* and cp* are the radioactive concentrations of hormone in tissue i and plasma, respectively, so that bi =(Ci) bp (2) In order to compare the relative strength of cellular binding for T3 and T4 as in Table IV, where the subscripts 3 and 4 refer to T3 and T4, respectively. The turnovers of hormone, expressed in micrograms per day, can be defined S = ktVtc, (5) where kt = the total fractional removal rate from the body (day-') and cq = the concentration of nonradioactive hormone in plasma (pg/liter).
By definition, ktVt = MCR, the total metabolic clearance rate (liters/day) and under steady-state conditions S = keVccp (6) where k. = fractional removal rate of hormone from the lumped cellular compartment. Thus from equations 5 and 6, ktVt = k0V0 and ktVt
C=Vc
The cellular metabolic clearance rate is defined as Bckc.
From equations 1 and 7 it follows that Bckc = ktVtbp = (MCR)b, (8) Cellular Metabolism of T3 and T4 1023 (7) and (Bke)3s (MCR)3(b)4 (9) 
